Lagos
University Teaching Hospital (LUTH) Photo credit: Hotels.ng
|
• Resident doctor infected, isolated in hospital’s ward
There is the fear of an
outbreak of Lassa fever in the country as the Lagos University Teaching
Hospital (LUTH) yesterday confirmed that two patients treated have died within
a few days of admission in the past one week.
The
Guardian Nigeria report continues:
The
Chief Medical Director (CMD) of LUTH, Prof. Chris Bode, told journalists that
the two patients who were at the advanced stage of the infection died despite
efforts to save their lives.
“The
first was a 32-year-old pregnant lady with bleeding disorder who died after a
stillbirth. Post-mortem examination had been conducted before her Lassa fever
status was eventually suspected and confirmed. No less than 100 different
hospital workers exposed to this index case are currently being monitored,” he
said.
Bode,
who is also a professor of paediatrics, said a resident doctor from the
Department of Anatomic and Molecular Pathology who took part in the autopsy was
later confirmed with the disease and is currently on admission and responding
well to treatment at the Isolation Ward of LUTH.
The
CMD who visited the Isolation Centre yesterday in the company of his top
management staff assured doctors of the hospital’s full support.
The
paediatric surgeon enjoined all LUTH workers to maintain a heightened level of
alert in the wake of this new outbreak and observe universal precautions in
handling all suspected cases of this viral hemorrhagic fever.
He
urged Nigerians to notify the response team in LUTH in case of any suspected
case of Lassa fever through the following phone numbers: 08058019466,
08058744780, 07035521015 and 08023299445.
The
medical expert noted that LUTH has always worked closely with officials of the
Lagos State Ministry of Health in handling a number of diseases of public
importance such as rabies, cholera, Lassa fever and the recent diarrhoea
disease at the Queen’s College. He said both the Lagos State Ministry of Health
and the Federal Ministry of Health have responded swiftly to contain the
current Lassa fever outbreak by mobilizing human and material resources to
trace the sources and extent of the disease, follow up on potential contacts,
identify early and test suspected cases.
The
LUTH boss said there were adequate materials for the containment of the disease
while drugs have been made available to treat anyone confirmed to have it. The
Centre for Disease Control (CDC) in Nigeria has also been contacted and two
other suspected cases from Lagos State are also currently admitted and
quarantined while confirmatory laboratory tests are ongoing.
According
to the World Health Organization (WHO), Lassa fever is an acute viral
haemorrhagic illness of two-21 days duration that occurs in West Africa. The
Lassa virus is transmitted to humans via contact with food or household items
contaminated with rodent urine or faeces. Person-to-person infections and
laboratory transmission can also occur, particularly in hospitals lacking
adequate infection prevention and control measures.
Lassa
fever is known to be endemic in Benin, Ghana, Guinea, Liberia, Mali, Sierra
Leone, and Nigeria, but probably exists in other West African countries as
well. The overall case-fatality rate is one per cent. Observed case-fatality
rate among patients hospitalized with severe cases of Lassa fever is 15 per
cent.
It
has been shown that early supportive care with rehydration and symptomatic
treatment improves survival.
The
virus is zoonotic, or animal-borne. About 80 per cent of human infections are
without symptoms; the remaining cases have severe multiple organ disease, where
the virus affects several organs in the body, such as the liver, spleen and
kidneys. Lassa fever is a significant cause of severe illness and death.
According
to the WHO, the reservoir or host of the Lassa virus is the “multimammate rat”
called mastomys natalensis which has
many breasts and lives in the bush and around residential areas. The virus is
shed in the urine and droppings of the rats hence can be transmitted through
direct contact, touching objects or eating food contaminated with these
materials or through cuts or sores. Transmission also occurs in health
facilities where infection prevention and control practices are not observed.
A
WHO fact sheet on Lassa fever noted that it occurs in all age groups and both
sexes. Persons at greatest risk are those living in rural areas where mastomys
are usually found, especially in communities with poor sanitation or crowded
living conditions. Health workers are at risk if Lassa fever is not suspected
or while caring for Lassa fever patients in the absence of proper barrier
nursing and infection control practices.
According
to the WHO, the onset of the disease, when it is symptomatic, is usually gradual,
starting with fever, general weakness, muscle and joint pains, prostration and
malaise. After a few days, headache, sore throat, muscle pain, chest pain,
nausea, vomiting, diarrhoea, cough, and abdominal pain may follow. In severe
cases facial swelling, fluid in the lung cavity, bleeding from the mouth, nose,
vagina or gastrointestinal tract and low blood pressure may develop. Protein
may be noted in the urine. Shock, seizures, tremor, disorientation, and coma
may be seen in the later stages. Deafness occurs in 25 per cent of patients who
survive the disease. In half of these cases, hearing returns partially after
one – three months. Transient hair loss and gait disturbance may occur during
recovery. Patients may die from shock.
The
only known specific treatment for Lassa fever is Ribavirin which may be
effective if given within the first six days of illness.
It
should be given intravenously for ten (10) days. Supportive treatment should
include; Paracetamol, Vitamin K (Phytamenadione), Heamacel, Ringers lactate,
antimalaria and antibiotics- start by I.V. If patient is severely anaemic,
consider transfusion.
Unfortunately,
there is currently no vaccine that protects against Lassa fever.
According
to the WHO, prevention of Lassa fever relies on promoting good “community
hygiene” to discourage rodents from entering homes. Effective measures include
storing grain and other foodstuffs in rodent-proof containers, disposing of
garbage far from the home and maintaining clean households.
Before
now and besides Lagos, active transmission of Lassa fever has been reported in
five states (Bauchi, Edo, Ogun, Ondo, and Plateau) in the past three weeks.
Altogether, 13 new suspected cases were reported from four states during the
last week of July: Plateau (five), Ondo (five) Bauchi (two), and Ogun (one),
including two deaths.
Nigeria
is one of several West African countries in which Lassa fever is endemic, with
seasonal outbreaks occurring annually between December and June. In 2016, the
country reported 273 suspected cases and 149 deaths (case fatality rate 55 per
cent) from 23 states. In 2017, Benin, Burkina Faso, Sierra Leone, and Togo
experienced outbreaks that have since been controlled.
The
current outbreak of Lassa fever in Nigeria, however, is continuing beyond the normal
season.
This persistent Lassa fever outbreak comes against the background of a protracted humanitarian crisis in the northern part of the country, as well as outbreaks of cholera and hepatitis E.
No comments:
Post a Comment